ACADIA Pharmaceuticals Inc.

ACADNASDAQHealthcare● Active

$21.33

$-0.23(-1.07%)

Market Cap$3.7B

P/E Ratio—

52W High$28.35

52W Low$19.69

Avg Volume1.8M

Open$21.70

Beta0.83

Net Income Financials Revenue

ACADIA Pharmaceuticals Inc. (ACAD) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ACAD · net income · updated Jun 8, 2026

Core profitability metrics

ACAD · net income · margin · TTM · CAGR

Net income was $391.0M for FY2025 (fiscal year ending 2025-12-31), up 72.7% year-over-year. Net profit margin was 36.5%. Based on available data, ACADIA Pharmaceuticals Inc. has been profitable since at least 2024.

FY2025 Net Income$391.0M▲ +72.7% YoY

Trailing 12M (TTM)$375.6Mtrailing 4 quarters sum

Net Profit Margin36.5%$391.0M ÷ $1.07B

YoY Change+72.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2024

▸ FMP /income-statement · Annual · ACAD net income history · ACAD profit margin

Annual net income data

ACAD · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$391.0M▲ +72.7%36.5%$1.07B

FY2024★ First Profit$226.5M▲ +469.5%23.6%$957.8M

FY2023Loss−$61.3M▲ +71.6%-8.4%$726.4M

FY2022Loss−$216.0M▼ 28.7%-41.8%$517.2M

FY2021Loss−$167.9M▲ +40.4%-34.7%$484.1M

Net income vs peers (Healthcare)

ACAD vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

ACADIA Pharmaceuticals Inc.YOU

ACAD

$391.0M+72.7%36.5%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

ACADIA Pharmaceuticals Inc. (ACAD) reported net income of $391.0M for FY2025 (fiscal year ending 2025-12-31), up 72.7% year-over-year. The net profit margin was 36.5% — meaning the company kept $0.36 of every dollar of revenue as profit.

Based on available data, ACADIA Pharmaceuticals Inc. has been profitable since at least 2024. Net income reached a peak of $391.0M in FY2025. Data available for 15 fiscal years.

ACADIA Pharmaceuticals Inc.'s net profit margin was 36.5% for FY2025, based on the latest annual results.

Investors sometimes search for "ACADIA Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from ACAD net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ACAD net income · 5 questions

ACADIA Pharmaceuticals Inc. is profitable. The company reported net income of $391.0M for FY2025, a net profit margin of 36.5%. Net income was up 72.7% year-over-year. Based on available data, ACADIA Pharmaceuticals Inc. has been profitable since at least 2024.

is ACAD profitabledoes ACAD make a profitACAD profitabilityACAD profitable company

▸ Source: FMP /income-statement · GAAP · ACADIA Pharmaceuticals Inc. · ACADIA Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026